massdevice_logo_pms179
December 9th, 2016 | News

Vapogenix Closes $8.2M Series C for Topical Painkiller

Vapogenix Inc. said yesterday that it raised $8.2 million in a Series C financing round to fund the development of its locally-acting painkiller. Pamoja Capital and a group of pain physicians led the round. The Houston, Texas-based company’s technology is …

drug-delivery-business-news-logo
December 9th, 2016 | News

Vapogenix Closes $8.2M Series C for Topical Painkiller

Vapogenix Inc. said yesterday that it raised $8.2 million in a Series C financing round to fund the development of its locally-acting painkiller. Pamoja Capital and a group of pain physicians led the round. The Houston, Texas-based company’s technology is …

fortune-logo-2016-840x485
December 9th, 2016 | News

Term Sheet — Friday, December 9

Vapogenix, a Houston, Texas-based developer of non-opioid medicine for localized pain, raised $8.2 million in new funding from Pamoja Capital, among other investors. Continue reading here…

nasdaq-apo
December 8th, 2016 | News

Vapogenix Secures $8.2 Million in Series C Funding to Advance Innovative Therapy for Wound Pain

HOUSTON, Dec. 08, 2016 (GLOBE NEWSWIRE) — Vapogenix, Inc., a clinical-stage company developing a topical, non-opioid medicine for localized pain, has raised $8.2 million to advance the development of its lead product, a locally-acting analgesic based on volatile anesthetics (VAs), …

massdevice_logo_pms179
December 9th, 2016 | News

Vapogenix Closes $8.2M Series C for Topical Painkiller

Vapogenix Inc. said yesterday that it raised $8.2 million in a Series C financing round to fund the development of its locally-acting painkiller. Pamoja Capital and a group of pain physicians led the round. The Houston, Texas-based company’s technology is …

drug-delivery-business-news-logo
December 9th, 2016 | News

Vapogenix Closes $8.2M Series C for Topical Painkiller

Vapogenix Inc. said yesterday that it raised $8.2 million in a Series C financing round to fund the development of its locally-acting painkiller. Pamoja Capital and a group of pain physicians led the round. The Houston, Texas-based company’s technology is …

fortune-logo-2016-840x485
December 9th, 2016 | News

Term Sheet — Friday, December 9

Vapogenix, a Houston, Texas-based developer of non-opioid medicine for localized pain, raised $8.2 million in new funding from Pamoja Capital, among other investors. Continue reading here…

nasdaq-apo
December 8th, 2016 | News

Vapogenix Secures $8.2 Million in Series C Funding to Advance Innovative Therapy for Wound Pain

HOUSTON, Dec. 08, 2016 (GLOBE NEWSWIRE) — Vapogenix, Inc., a clinical-stage company developing a topical, non-opioid medicine for localized pain, has raised $8.2 million to advance the development of its lead product, a locally-acting analgesic based on volatile anesthetics (VAs), …